Cambiar Investors LLC Trims Position in Addus HomeCare Co. (NASDAQ:ADUS)

Cambiar Investors LLC decreased its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 7.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,413 shares of the company’s stock after selling 1,320 shares during the quarter. Cambiar Investors LLC owned approximately 0.09% of Addus HomeCare worth $1,932,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ADUS. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Addus HomeCare in the 3rd quarter valued at about $1,622,000. JPMorgan Chase & Co. lifted its holdings in Addus HomeCare by 10.2% in the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after acquiring an additional 16,997 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in Addus HomeCare by 127.7% in the third quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock worth $8,555,000 after acquiring an additional 36,071 shares during the period. Principal Financial Group Inc. increased its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Finally, Quest Partners LLC increased its stake in Addus HomeCare by 4,087.0% during the third quarter. Quest Partners LLC now owns 11,263 shares of the company’s stock worth $1,498,000 after acquiring an additional 10,994 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Stephens boosted their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. JMP Securities started coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective for the company. Finally, StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $134.22.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock valued at $4,930,750 over the last 90 days. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $114.67 on Wednesday. The stock’s 50-day moving average is $126.47 and its two-hundred day moving average is $127.28. The company has a market cap of $2.08 billion, a price-to-earnings ratio of 26.24, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.72.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.